HBV RNA Predicts the Risk of Off‐Treatment Relapse in Chronic Hepatitis B Patients With NAs Therapy: A Systematic Review and Meta‐Analysis

Documenti analoghi

• Limited Value of HBV‐RNA for Relapse Prediction After Nucleos(t)ide Analogue Withdrawal in HBeAg‐negative Hepatitis B Patients
  di: Valerie Ohlendorf, et al.
  Pubblicazione: (2024)
• Clinical Observational Study on HBV Reactivation After Direct‐Acting Antiviral Therapy in HCV / HBV Coinfected Patients in Guizhou, China
  di: Mei Wang, et al.
  Pubblicazione: (2025)
• Perceived HBV‐Related Stigma Is Associated With Lower Antiviral Medication Adherence in Patients With Chronic Hepatitis B
  di: Hee‐Soon Juon, et al.
  Pubblicazione: (2025)
• Biogenesis of serum HBV RNA and clinical phenomena of serum HBV RNA in chronic hepatitis B patients before and after receiving nucleos(t)ide analogues therapy
  di: Liandong Wu, et al.
  Pubblicazione: (2024)
• Multiple Low‐Level Viraemia Suggest Hindered Liver Fibrosis Regression in Chronic Hepatitis B Patients During Antiviral Therapy
  di: Zhengzhao Lu, et al.
  Pubblicazione: (2024)